Conditions: Perennial Allergic Rhinitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 703
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine if one allergy treatment (0.15% azelastine hydrochloride) is as safe as mometasone furoate (nasonex) alone.

Detailed description:

Arms:
arm 1: 0.15% azelastine hydrochloride 1644 mcg arm 2: Mometasone furoate 200 mcg

Interventions: intervention 1: 0.15% azelastine hydrochloride intervention 2: Mometasone furoate
Intervention descriptions: intervention 1: 1644 mcg (205.5 mcg/spray) 2 sprays per nostril twice a day/AM and PM intervention 2: 200 mcg (50 mcg/spray) 2 sprays per nostril Once a day (AM)

Protocol document: